Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023
SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Related news for (ADPT)
- Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
- 24/7 Market News Snapshot 05 August, 2025 – Adaptive Biotechnologies Corporation Common Stock (NASDAQ:ADPT)
- Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
- Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma